Journal Logo

Instructions for Authors

Revised February 26, 2019

All manuscripts must be submitted online via Editorial Manager at:


JBJS Case Connector (JBJS CC) welcomes submissions​ of rare or unusual case reports from around the world as well as reports describing complications involving devices, conditions, or procedures for which long-term follow-up data have not yet been published.

JBJS Case Connector is currently indexed in MEDLINE/PubMed, Scopus, and CrossRef. It is also accessible via Ovid.

Articles submitted or transferred to JBJS CC undergo double-blinded peer review, with the Editorial Office removing all author and institution identifiers before sending papers to reviewers.

Conditions for Submission
Submission Overview and Manuscript Structure
What to Expect After Submission
Public Access Policy
Open-Access Option
Embargo Policy for Accepted Manuscripts
Appeals Process
Supplementary Links

Conditions for Submission

  • Manuscripts should focus on three (3) or fewer patients in order to be considered as a case report.
  • Articles are accepted for exclusive publication in JBJS Case Connector. Previous presentation at a scientific meeting, and/or publication of the abstract in conjunction with the meeting, does not preclude publication of the article; however, this information must be disclosed in a cover letter at the time of submission. Previously published articles, including those published in non-English-language journals, are not accepted. JBJS Case Connector does not accept manuscript submissions involving human subjects (or their medical records) that have been previously posted to preprint servers.
  • Published articles and illustrations become the property of The Journal of Bone and Joint Surgery, Inc.
  • Patient consent must be obtained for all human studies, and all manuscripts must include a statement indicating that such consent was obtained. If such consent was not obtained, a letter of explanation indicating that the authors have obtained Institutional Review Board (IRB) approval/exemption to report the case without consent is acceptable.
  • For cases in which the patient is deceased and the report includes no protected health information or other information that could reasonably lead to identification of the patient, we encourage authors to contact a family member for verbal consent. For cases in which the patient is deceased and the report includes information that is unique enough that the patient could be identified, we require authors to either contact a family member for verbal consent or obtain a waiver from the appropriate IRB stating that such consent is not necessary. The authors are responsible for obtaining and retaining the documentation of such permission; in order to protect patient confidentiality, this documentation should not be forwarded to JBJS, Inc.
  • Patient confidentiality must be protected in accordance with the U.S. Health Insurance Portability and Accountability Act (HIPAA). See our complete Ethics Policy for additional information.

Submission Overview and Manuscript Structure

Please refer to our Recommendations for Writing a Case Report prior to submitting your case.

Authors should adhere to the ICMJE's "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals."

All manuscripts must be submitted through Editorial Manager (a web-based service). Corresponding authors must register via and will then receive an e-mail containing a Username and Password that will allow access for manuscript submission. If you currently have a JBJS Editorial Manager username and password, these will also give you access to the JBJS Case Connector site.

Authors should register with ORCID and include their ORCID identifier in their Editorial Manager profile. Authors can obtain this identifier through Editorial Manager when they submit their article; it will not be possible to submit an article without such an identifier.

The following items must be submitted in order to be considered for publication:

  1. Title Page: including (1) article title, (2) authors' names, in the order in which they should appear, and academic degrees, (3) institution(s) at which the work was performed, (4) institution(s) (and city and state or country) with which each author is affiliated, and (5) corresponding author and his/her e-mail address.
  2. Manuscript Structure: Case reports must be submitted as a Word file and cannot exceed 1,600 words, including the Abstract but excluding references and figure legends. Additionally, no more than three (3) cases should be presented in the report. Manuscripts not meeting these specifications will be returned for modification.

    Case reports should consist of the following elements:
    • A Structured Abstract of no more than 100 words, consisting of two headings: Case (which summarizes the salient features of the case) and Conclusion (which states the main learning point and novelty of the case).
    • The body should consist of:
      • Introduction: Briefly describe the history, frequency of occurrence, typical presentation, and progression of the condition. If the case represents a new condition, describe the condition in detail. Include a short summary of a literature search.
      • Statement of Informed Consent: All case reports must include a statement that each patient was informed that data concerning the case would be submitted for publication and that each patient agreed. We do not require, nor will we accept, consent forms signed by the patient. See "Conditions for Submission" for additional information.
      • Case Report: Individually describe each patient's demographic information, medical history, signs and symptoms, diagnostic test results, treatment, and outcome. If reporting on more than one patient, assign a case number to each patient. A minimum of one to two years of follow-up with documentation of clinical, radiographic, and functional outcome information is preferred in order for the case to be of maximum assistance to clinicians facing treatment decisions for patients with similar clinical problems. Authors seeking to submit a manuscript with less than one year of follow-up can request an exemption but should provide a justification for this request in the form of a cover letter that accompanies the submission.
      • Discussion: Describe any conclusions that can be drawn from the case(s) and the potential impact on our understanding or treatment of the condition.
    • A reference section, in PubMed/Index Medicus format, must be included after the manuscript text. Number the references according to the order of citation in the text (not alphabetically), and cite all references in the text.
    • Figure legends must be included at the end of the manuscript text file, after the References section, for all images. Explain what each figure shows. Identify machine settings for magnetic resonance images, and give the magnification of all photomicrographs. Define all arrows and other such indicators appearing on the figure.
  3. Tables (optional) must be labeled individually and uploaded as separate Word or Excel format files.
  4. Figures (optional) must be submitted in TIFF or EPS format. No more than 12 separate image files may be submitted. Cite all figures, in order, in the text. See Guidelines for Figures for detailed instructions. Just as radiographic images are an important part of a case report, histological images should also be included when relevant, especially for case reports describing tumors or adverse local tissue reactions. For selected case reports that include histological images, authors may be given the option of inserting a link to a digital, high-resolution Whole Slide Image of an entire scanned microscopic slide.
  5. Videos (optional) must be uploaded to the Video Submissions Site according to our Author Video Guidelines. Instructions for upload can be found here.
  6. Copyright Transfer and Author Agreement (revised/accepted manuscripts only): All authors must sign a Copyright Transfer and Author Agreement granting JBJS, Inc. exclusive copyright to all material, except for previously copyrighted items (see #8 below) and video. Authors can maintain the copyright to videos but must complete the Video License Agreement granting JBJS, Inc. unlimited license to use the video online.
  7. Disclosure of Potential Conflicts of Interest (revised/accepted manuscripts only): Authors must complete an ICMJE Conflict of Interest Statement form for each submitted manuscript. As this form will not load properly when opened through a browser or e-mail client, download the PDF file directly to your computer and open with Adobe Acrobat or Reader. Scanned copies of the completed form are not acceptable. JBJS CC will post the forms online and will summarize the information in a disclosure statement that will appear in the article. The ICMJE forms have no bearing on the decision to accept a manuscript.
  8. Permission to Use Figures, Tables, and Videos Owned by Another Party (revised/accepted manuscripts only): Authors are responsible for obtaining permissions. Provide (1) a full citation for the previous publication and (2) a letter from the owner of the copyright granting permission for JBJS CC to reproduce the copyrighted material OR a completed permissions form stating the date when permission was requested and the approximate date when the permission is expected to be received.


  • There is a general limit of six (6) authors. Effective January 1, 2018, each author must indicate his/her contributor roles on the "Add/Edit/Remove Authors" screen in Editorial Manager in accordance with the CRediT Taxonomy initiative.
  • Each author must have contributed significantly to, and be willing to take public responsibility for, one or more aspects of the study: its design, data acquisition, and/or data analysis and interpretation. All authors must have been actively involved in the drafting and critical revision of the manuscript, and all must provide final approval of the version to be published. If a research group is designated as the author of an article, see our Group Authorship instructions for guidance.
  • Individuals who have contributed to only one section of the manuscript or have contributed only cases should be credited in an acknowledgment footnote. See the ICMJE author definitions page for additional guidance regarding authors and non-author contributors.
  • A non-author writer who is employed by a commercial organization must be declared, along with the name of his or her employer, in an acknowledgment footnote. The non-author writer must also submit a Conflict of Interest Statement.
  • The order of names reflects only the preference of the authors and the corresponding author is not designated in the final published version of an article. Any change in authorship after the initial review process necessitates a signed letter, generally from all authors, agreeing to the change.

What to Expect After Submission

  • Manuscripts are evaluated by the JBJS editorial staff and are assigned to one of the Co-Editors of JBJS CC. In most cases, the Co-Editor then sends the paper to consultant reviewers.
  • If a reviewer has a conflict of interest regarding the subject matter of a manuscript, he or she must disclose the conflict to the Co-Editors of JBJS CC, who make the final decision regarding acceptance or rejection of the manuscript. The Co-Editors have disclosed all known conflicts and competing interests on their ICMJE forms, which are available on the Editorial Board page.
  • If reviewers disagree regarding the acceptance of a manuscript, additional consultant reviewers may be recruited to review the paper, or the decision may be arbitrated at a workshop, which JBJS holds several times a year.
  • The time between receipt of a submitted manuscript and the decision regarding its publication has averaged six weeks, but it may be longer.
  • The corresponding author is informed of the publication date of an accepted manuscript approximately six weeks before publication.

Public Access Policy

To enable authors to comply with the requirements of outside funding bodies, JBJS, Inc. will deposit, into the PubMed Central (PMC) Archive, the final published version of any article funded by a body requiring such deposit. Thus, authors should identify on the Copyright Transfer Agreement (CTA) whether their article is based on research funded in whole or in part by the National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), Wellcome Trust, Research Councils UK (RCUK), or another funding agency requiring deposit to a repository. JBJS, Inc., as a service to its authors, will then identify these articles to the National Library of Medicine (NLM) and transmit them to PMC. PMC will make these articles freely available after an embargo period that satisfies the funding agency's requirements (or immediately upon publication if the author has chosen the open-access option). JBJS, Inc. will not be held responsible for retroactive deposits to PMC if the author has not identified the funding agency on the CTA form.

Open-Access Option

JBJS, Inc. offers an open-access option to authors who want readers around the globe to have free, perpetual, unrestricted online access to their article on the JBJS Case Connector web site immediately upon publication. Authors are offered this option after their article has been accepted for publication to ensure that their choice has no influence on the peer-review or acceptance process. All articles submitted to JBJS CC are subjected to our standard peer-review process and are accepted or rejected on the basis of their merit only.

Authors retain copyright for all articles published with the open-access option. Authors grant JBJS, Inc. and its publishing partner Wolters Kluwer the exclusive license to publish the article and to identify themselves as the original publisher. The Wolters Kluwer Open Access License Agreement (the "Open Access License") supersedes and replaces Section 1.a of the JBJS CC Copyright Transfer and Author Agreement signed by authors (on manuscript submission), for authors who later choose the open-access option (on acceptance). Open-access articles are published under the terms of the standard Creative Commons Attribution‐NonCommercial-NoDerivatives International (CC BY-NC-ND) license, or, if mandated by the authors' funding body, the Creative Commons Attribution International (CC BY) license, both of which permit copying and redistribution of the material in any medium or format.

The article processing charge for the open-access option is $2,400 (CC BY-NC-ND license) or $2,850 (CC BY license, which is offered only to authors who have received funding that mandates the CC BY license). The publication fee is charged on acceptance of the article and must be paid in full within 30 days by credit card by the author, funding agency, or institution.

For more information, please see our FAQs.

Embargo Policy for Accepted Manuscripts

Specific information contained in your article cannot be discussed with the media, published, posted online, or otherwise placed in the public domain until after publication. It is the responsibility of the corresponding author to ensure that all coauthors are aware of this policy. See our Confidentiality and Embargo Policy for additional information regarding this policy, including exceptions.

Appeals Process

JBJS conducts workshops several times per year, during which contested decisions may be arbitrated.

An author who wishes to appeal a decision should contact within 30 days after the final decision with a detailed letter that explains the reason for the appeal. This letter will considered by the handling editor, and the author will be notified of the final decision. Decisions on appeals are final, without exception. Priority is given to new submissions, so the appeal process may take longer than the original submission process.

Supplementary Links

Recommendations for Writing a Case Report
Ethics Policy
Guidelines for Figures
Group Authorship Guidelines
Author Video Guidelines
Confidentiality and Embargo Policy
Hybrid Open-Access FAQ


Copyright Transfer Form
Conflict of Interest Form (must be downloaded and completed using Adobe Acrobat or Reader)
Video License Agreement
Figure Permissions Form
Open Access License Agreement (open-access option only)